Increase in the number of invasive Haemophilus influenzae type b infections;Toename van het aantal invasieve infecties door Haemophilus influenzae type b

Nederlands Tijdschrift voor Geneeskunde

Volumn 149, Issue 49, 2005, Pages 2738-2742

  Spanjaard, L ^a   Van Den Hof, S ^b   De Melker, H E ^b   Vermeer De Bondt, P E ^b   Van Der Ende, A ^a   Rijkers, G T ^c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

ARTICLE; BACTERIAL MENINGITIS; BACTERIUM ISOLATE; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; HYPOTHESIS; IMMUNITY; INFECTION SENSITIVITY; INFLUENZA; INFLUENZA VACCINATION; MASS IMMUNIZATION; NETHERLANDS; PREVALENCE; TREATMENT FAILURE;

HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; INCIDENCE; NETHERLANDS; POLYSACCHARIDES, BACTERIAL; PREVALENCE; SENTINEL SURVEILLANCE; VIRULENCE;

EID: 28844503805     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Neijens HJ, Groot R de, Dzoljic-Danilovic G. Haemophilus influenzae type b-infecties bij kinderen. Ned Tijdschr Geneeskd. 1991;135:13-6.
2. Alphen L van, Spanjaard L, Ende A van der, Schuurman I, Dankert J. Effect of nationwide vaccination of 3-month-old infants in the Netherlands with conjugate Haemophilus influenzae type b vaccine: high efficacy and lack of herd immunity. J Pediatr. 1997;131:869-73.
3. Conyn-van Spaendonck MAE, Veldhuijzen IK, Suijkerbuijk AWM, Hirasing RA. Sterke daling van het aantal invasieve infecties door Haemophilus influenzae in de eerste 4 jaar na de introductie van de vaccinatie van kinderen tegen H. influenzae type b. Ned Tijdschr Geneeskd. 2000;144:1069-73.
4. Rümke HC, Visser HKA. Vaccinaties op de kinderleeftijd anno 2004. I. Effectiviteit en acceptatie van het Rijksvaccinatieprogramma. Ned Tijdschr Geneeskd. 2004;148:350-63.
5. Rijkers GT, Vermeer-de Bondt PE, Spanjaard L, Breukels MA, Sanders EA. Return of Haemophilus influenzae type b infections. Lancet. 2003;361:1563-4.
6. Netherlands Reference Laboratory for Bacterial Meningitis. Annual report 2003. Amsterdam: Universiteit van Amsterdam; 2004.
7. Breukels MA, Spanjaard L, Sanders LA, Rijkers GT. Immunological characterization of conjugated Haemophilus influenzae type b vaccine failure in infants. Clin Infect Dis. 2001;32:1700-5.
8. Breukels MA, Jol-van der Zijde E, Tol MJ van, Rijkers GT. Concentration and avidity of anti-Haemophilus influenzae type b (Hib) antibodies in serum samples obtained from patients for whom Hib vaccination failed. Clin Infect Dis. 2002;34:191-7.
9. Garner D, Weston V. Effectiveness of vaccination for Haemophilus influenzae type b. Lancet. 2003;361:395-6.
10. Peltola H, Salo E, Saxen H. Incidence of Haemophilus influenzae type b meningitis during 18 years of vaccine use: observational study using routine hospital data. BMJ. 2005;330:18-9.
11. n Heath PT, Ramsay ME. Haemophilus influenzae type b vaccine - booster campaign. BMJ. 2003;326:1158-9.
12. McVernon J, Andrews N, Slack MPE, Ramsay ME. Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis. Lancet. 2003;361:1521-3.
13. Veldhuijzen IK, Conyn-van Spaendonck MAE, Suijkerbuijk AWM, Alphen L van, Dankert J. Three years of surveillance of invasive infections by Haemophilus influenzae after introduction of immunisation in the National Immunisation Programme. RIVM Rapport nr 213676007. Bilthoven: RIVM; 1997.
14. Eskola J, Kayhty H, Takala AK, Peltola H, Ronnberg PR, Kela E, et al. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. N Engl J Med. 1990;323:1381-7.
15. Tejedor JC, Omenaca F, Garcia-Sicilia J, Verdaguer J, Esso D van, Esporrin C, et al. Immunogenicity and reactogenicity of a three-dose primary vaccination course with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-haemophilus influenzae type b vaccine coadministered with a meningococcal C conjugate vaccine. Pediatr Infect Dis J. 2004;23:1109-15.
16. Labadie J, Sundermann LC, Rümke HC. Multi-center study on the simultaneous administration of DPT-IPV and Hib PRP-T vaccines. Part I. Immunogenicity. DPT-IPV - Hib Vaccine Study Group. RIVM-rapport nr 124001003. Bilthoven: RIVM; 1996.
17. Rümke HC, Schellekens JFP. Acellulaire kinkhoestvaccins in het Rijksvaccinatieprogramma. Infectieziekten Bulletin. 2005;16:15-7.
18. Schouls LM, Ende A van der, Pol I van de, Schot C, Spanjaard L, Vauterin P, et al. Increase in genetic diversity of Haemophilus influenzae serotype b (Hib) strains after introduction of Hib vaccination in The Netherlands. J Clin Microbiol. 2005;43:2741-9.
19. Murphy TV, Pastor P, Medley F, Osterholm MT, Granoff DM. Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine. J Pediatr. 1993;122:517-23.
20. Heath PT, McVernon J. The UK Hib-vaccine experience. Arch Dis Child. 2002;86:396-9.
21. McVernon J, Mitchison NA, Moxon ER. T helper cells and efficacy of Haemophilus influenzae type b conjugate vaccination. Lancet Infect Dis. 2004;4:40-3.